Y-Intercept (HK)’s KalVista Pharmaceuticals KALV Stock Holding History

Y-Intercept (HK)’s Portfolio KALV Stock Details KALV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-33,776	Closed	-$680K	–	1953
2026 Q1	$680K	Buy	+33,776	New	+$544K	0.01%	1176

Other funds holding KALV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Y-Intercept (HK)'s KALV Position: Q2 2026 in Review

Y-Intercept (HK) sold out of KalVista Pharmaceuticals (KALV) in Q2 2026, closing a stake of 33,776 shares — an estimated $680K sold.

Y-Intercept (HK) first reported a position in KALV in Q1 2026 and held it in 1 quarter. The position peaked at $680K in Q1 2026. 1 fund tracked by Wall St. Rank holds KALV as of Q2 2026.

Y-Intercept (HK) reported no remaining KalVista Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Y-Intercept (HK) sold 33,776 KalVista Pharmaceuticals shares in Q2 2026, an estimated $680K.
Y-Intercept (HK) first reported a position in KalVista Pharmaceuticals in Q1 2026 and held it in 1 quarter.
Y-Intercept (HK)'s KalVista Pharmaceuticals position peaked at $680K in Q1 2026.
1 fund tracked by Wall St. Rank held KalVista Pharmaceuticals as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.